Not admitted · Not a forecast
Rules 1.1.0 · as of 14 Sep 2026
Owen Scott Muir · Said 11 Jul 2022 · owen-0068
Quote
Not a forecast
“SNT treatment is not yet FDA cleared, but it does have FDA Breakthrough status, which means it’s so promising that the approval process has been sped up.”
Regulatory status of SNT as of July 2022: not FDA cleared, holds Breakthrough designation; the author frames this as an accelerated path toward approval.
Descriptive, retrospective, or a statement of preference; no future state asserted.